![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1540, 2006-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram superior to citalopram in depression
Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Spotlight on the Pharmacoeconomics of Escitalopram in Depression
CNS Drugs, Vol. 18, Iss. 7, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram's dominance dulls duloxetine in depression
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 551, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Long-term escitalopram beats paroxetine for severe depression
Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram, PST may prevent depression after stroke
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :